Sign up to save your podcasts
Or
Share 105 - Unraveling the Mystery of P2Y12 Inhibitors: Clinical Pearls and Comparative Evidence
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
105 - Unraveling the Mystery of P2Y12 Inhibitors: Clinical Pearls and Comparative Evidence
In this episode, we review the three oral P2Y12 inhibitors on the market (clopidogrel, prasugrel, ticagrelor) and discuss each agent’s clinical pearls, comparative effectiveness, and unique precautions.
View all episodes
By Sean P. Kane, PharmD; Khyati Patel, PharmD
4.9
639639 ratings
In this episode, we review the three oral P2Y12 inhibitors on the market (clopidogrel, prasugrel, ticagrelor) and discuss each agent’s clinical pearls, comparative effectiveness, and unique precautions.
More shows like HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast
View all
JAMA Editors' Summary
139 Listeners
EMCrit FOAM Feed
1,867 Listeners
NEJM This Week
321 Listeners
Emergency Medicine Cases
534 Listeners
JAMA Clinical Reviews
502 Listeners
Frankly Speaking About Family Medicine
253 Listeners
The Curbsiders Internal Medicine Podcast
3,330 Listeners
Core IM | Internal Medicine Podcast
1,110 Listeners
CorConsult Rx: Evidence-Based Medicine and Pharmacy
399 Listeners
Real Life Pharmacology - Pharmacology Education for Health Care Professionals
713 Listeners
Annals On Call Podcast
195 Listeners
Run the List
254 Listeners
The Curious Clinicians
367 Listeners
Ninja Nerd
289 Listeners
Docs Who Lift
389 Listeners